Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / matter-status-report-q3-2022.docx
matter-status-report-q3-2022.docx
Parties
HARKNESS LLP
Penterra Pharmaceuticals Corp
Examination Defense Penterra Pharmaceuticals Corp
Whitmore Valuation Group LLC
Associates LLP
Penterra Manufacturing Ireland Ltd
Harborview Corp
Taxpayer Information Penterra Pharmaceuticals Corp
Dates
October 1, 2022
July 1, 2022
September 30, 2022
May 16, 2022
June 2, 2022
June 8, 2022
June 20, 2022
June 28, 2022
March 15, 2012
July 1, 2012
Amounts
$6.82
$1.47
$312
€2.14
€1.06
$650
€47.2
$62.4
$4.5
$7.0
Obligations
The memorandum addresses the requirements for CSA qualification, including the documentary requirements, the rules for computing reasonably anticipated benefit shares, the methods available for valuing PCT payments (income method, acquisition price method, market capitalization method, residual profit split method), and the compliance standards that must be satisfied to maintain CSA qualification
5% royalty rate for legacy compounds and identifies the standards that the IRS must satisfy to adjust the rate under IRC § 482